Brian Melloy, MD
Family Medicine · Rogers, ARNPI 1457716813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Merz North America, Inc. at 35.1% of the total. Reporting peaked in 2022 at $130 and has fallen 76.6% since, to $31 in 2024. That places this record below the midpoint for family medicine clinicians in AR, where the typical reported total is $553.
Across 6 payments — averaging $61.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$130
- Redhill Biopharma Inc.$113
- Gilead$62
- Revance Therapeutics, Inc.$31
- Amgen$20
- Currax Pharmaceuticals LLC$15
What the payments were for
- Food & beverage$371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 1 | $130 |
| Redhill Biopharma Inc. | 1 | $113 |
| Gilead | 1 | $62 |
| Revance Therapeutics, Inc. | 1 | $31 |
| Amgen | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$371 in reported general payments places this provider in the 40th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $14,886 |
| Testosterone Cypionate | 13 | $431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $387 |
| Gabapentin | 28 | $339 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $331 |
| Levetiracetam | 13 | $165 |
| Potassium Chloride | 15 | $151 |
| Metoprolol Succinate | 15 | $124 |
| Oxycodone Hcl | 30 | $118 |
| Pantoprazole Sodium | 13 | $111 |
| Amlodipine Besylate | 27 | $109 |
| Memantine Hcl | 11 | $102 |
| Atorvastatin Calcium | 29 | $93 |
| Tamsulosin Hcl | 12 | $84 |
| ClopidogrelClopidogrel Bisulfate | 17 | $75 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rogers
- John SmileyRogers$13K
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
- Scott MusickBentonville$102K
- Broderick EatonWynne$49K
- Craig LevoyBentonville$30K
- Allen BeachyFort Smith$21K
- Hunter CarringtonHot Springs$20K
- Harold BettonLittle Rock$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.